Table 2 Surgical management of prosthetic and joint infections (weighted data)
| Q2C1 | Q2C2 | Q3C1 | Q3C2 | ||
|---|---|---|---|---|---|
| STRATEGY | DAIR | 2% (1/44.5) | 5% (2/40) | 23% (11/47) | 21% (11/53.5) |
| 1-stage | 91% (40.5/44.5) | 75% (30/40) | 82% (38.5/47) | 72% (38.5/53.5) | |
| 2-stage | 4% (2/44.5) | 20% (7/40) | 9% (4/47) | 7% (4/53.5) | |
| CEMENTa | 1-stage | 88% (26.5/30) | 42% (16.5/38.5) | ||
| 2-stage | 47% (7/15) | 8% (3/38,5) | |||